Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Spero Therapeutics Inc (NASDAQ:SPRO)

14.49
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
10.83
Today|||52-Week Range
15.40
--
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

--

--
AssetsCash5.7M10.3M----
 
 
 
Short Term Investment Cash5.4M4.6M----
 
 
 
Cash & Short Term Investments5.7M10.3M----
 
 
 
 
ReceivablesReceivables10.0K304.0K----
 
 
 
 
InventoriesInventories0.000.00------
 
Current AssetsOther Current Assets287.0K1.3M----
 
 
 
Current Assets6.0M11.9M----
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross960.0K1.8M----
 
 
 
Depreciation-11.0K-290.0K----
 
 
 
Other Assets189.0K350.0K----
 
 
 
Total Assets7.2M13.8M----
 
 
 
 
LiabilitiesAccounts Payable1.8M1.1M----
 
 
 
Accrued Expenses253.0K991.0K----
 
 
 
Other Current Liabilities4.1M3.7M----
 
 
 
Other Liabilities6.4M6.9M----
 
 
 
 
Total LiabilitiesOther Liabilities1.0M493.0K----
 
 
 
Total Liabilities7.4M7.4M----
 
 
 
 
EquityMinority Interest-3.0M-7.2M----
 
 
 
Preferred Stock18.3M55.6M----
 
 
 
Common Equity-18.1M-45.4M----
 
 
 
Total Shareholder Equity196.0K10.2M----
 
 
 
 
Share InformationCommon Shares Outstanding14.7M14.7M----
 
 
 
 
Addtl. Info.No data currently available for this section.